SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bernard Ravina, Shirley Eberly, David Oakes, Anthony E Lang, Vince Dodelet, Pieter Roos, Jennifer Harman, Ira Shoulson, Hyman M Schipper, Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study, Biomarkers in Medicine, 2015, 9, 2, 89

    CrossRef

  2. 2
    Caroline M. Tanner, Cheryl C. Meng, Bernard Ravina, Anthony Lang, Roger Kurlan, Kenneth Marek, David Oakes, John Seibyl, Emily Flagg, Lisa Gauger, Dolores D. Guest, Christopher G. Goetz, Karl Kieburtz, Diane DiEuliis, Stanley Fahn, Robin A. Elliott, Ira Shoulson, A practical approach to remote longitudinal follow-up of Parkinson's disease: The FOUND study, Movement Disorders, 2014, 29, 6
  3. 3
    Sushil Sharma, Carolyn Seungyoun Moon, Azza Khogali, Ali Haidous, Anthony Chabenne, Comfort Ojo, Miriana Jelebinkov, Yousef Kurdi, Manuchair Ebadi, Biomarkers in Parkinson’s disease (recent update), Neurochemistry International, 2013, 63, 3, 201

    CrossRef

  4. 4
    Sara Rosenblum, Margalit Samuel, Sharon Zlotnik, Ilana Erikh, Ilana Schlesinger, Handwriting as an objective tool for Parkinson’s disease diagnosis, Journal of Neurology, 2013, 260, 9, 2357

    CrossRef

  5. 5
    Brianne Magouirk Bettcher, Joel H. Kramer, Inflammation and clinical presentation in neurodegenerative disease: a volatile relationship, Neurocase, 2013, 19, 2, 182

    CrossRef

  6. 6
    Anthony E. Lang, Shirley Eberly, Christopher G. Goetz, Glenn Stebbins, David Oakes, Ken Marek, Bernard Ravina, Caroline M. Tanner, Ira Shoulson, Movement Disorder Society Unified Parkinson Disease Rating Scale experiences in daily living: Longitudinal changes and correlation with other assessments, Movement Disorders, 2013, 28, 14
  7. 7
    Richard J. Wurtman, Personalized medicine strategies for managing patients with Parkinsonism and cognitive deficits, Metabolism, 2013, 62, S27

    CrossRef

  8. 8
    James W. Little, Donald A. Falace, Craig S. Miller, Nelson L. Rhodus, Little and Falace's Dental Management of the Medically Compromised Patient, 2013,

    CrossRef

  9. 9
    Alexander Shtilbans, Claire Henchcliffe, Biomarkers in Parkinsonʼs disease, Current Opinion in Neurology, 2012, 25, 4, 460

    CrossRef

  10. 10
    Bernard Ravina, Kenneth Marek, Shirley Eberly, David Oakes, Roger Kurlan, Alberto Ascherio, Flint Beal, James Beck, Emily Flagg, Wendy R. Galpern, Jennifer Harman, Anthony E. Lang, Michael Schwarzschild, Caroline Tanner, Ira Shoulson, Dopamine transporter imaging is associated with long-term outcomes in Parkinson's disease, Movement Disorders, 2012, 27, 11
  11. 11
    John Seibyl, David Russell, Danna Jennings, Kenneth Marek, Neuroimaging Over the Course of Parkinson's Disease: From Early Detection of the At-Risk Patient to Improving Pharmacotherapy of Later-Stage Disease, Seminars in Nuclear Medicine, 2012, 42, 6, 406

    CrossRef

  12. 12
    Claire Henchcliffe, Un Kang, Parkinson's Disease, Second Edition, 2012,

    CrossRef

  13. 13
    John Seibyl, Ihor George Zubal, Danna Jennings, Kenneth Marek, P Murali Doraiswamy, Molecular PET imaging in multicenter Alzheimer’s therapeutic trials: current trends and implementation strategies, Expert Review of Neurotherapeutics, 2011, 11, 12, 1783

    CrossRef

  14. 14
    Monika Balzer-Geldsetzer, Ana Sofia Ferreira Braga da Costa, Martin Kronenbürger, Jörg B. Schulz, Sandra Röske, Annika Spottke, Ullrich Wüllner, Thomas Klockgether, Alexander Storch, Christine Schneider, Oliver Riedel, Hans-Ulrich Wittchen, Carola Seifried, Rüdiger Hilker, Nele Schmidt, Karsten Witt, Günther Deuschl, Brit Mollenhauer, Claudia Trenkwalder, Inga Liepelt-Scarfone, Susanne Gräber-Sultan, Daniela Berg, Thomas Gasser, Elke Kalbe, Maren Bodden, Wolfgang H. Oertel, Richard Dodel, Parkinson’s Disease and Dementia: A Longitudinal Study (DEMPARK), Neuroepidemiology, 2011, 37, 3-4, 168

    CrossRef

  15. 15
    Kenneth Marek, Danna Jennings, Shirley Lasch, Andrew Siderowf, Caroline Tanner, Tanya Simuni, Chris Coffey, Karl Kieburtz, Emily Flagg, Sohini Chowdhury, Werner Poewe, Brit Mollenhauer, Paracelsus-Elena Klinik, Todd Sherer, Mark Frasier, Claire Meunier, Alice Rudolph, Cindy Casaceli, John Seibyl, Susan Mendick, Norbert Schuff, Ying Zhang, Arthur Toga, Karen Crawford, Alison Ansbach, Pasquale De Blasio, Michele Piovella, John Trojanowski, Les Shaw, Andrew Singleton, Keith Hawkins, Jamie Eberling, Deborah Brooks, David Russell, Laura Leary, Stewart Factor, Barbara Sommerfeld, Penelope Hogarth, Emily Pighetti, Karen Williams, David Standaert, Stephanie Guthrie, Robert Hauser, Holly Delgado, Joseph Jankovic, Christine Hunter, Matthew Stern, Baochan Tran, Jim Leverenz, Marne Baca, Sam Frank, Cathi-Ann Thomas, Irene Richard, Cheryl Deeley, Linda Rees, Fabienne Sprenger, Elisabeth Lang, Holly Shill, Sanja Obradov, Hubert Fernandez, Adrienna Winters, Daniela Berg, Katharina Gauss, Douglas Galasko, Deborah Fontaine, Zoltan Mari, Melissa Gerstenhaber, David Brooks, Sophie Malloy, Paolo Barone, Katia Longo, Tom Comery, Bernard Ravina, Igor Grachev, Kim Gallagher, Michelle Collins, Katherine L. Widnell, Suzanne Ostrowizki, Paulo Fontoura, Tony Ho, Johan Luthman, Marcel van der Brug, Alastair D. Reith, Peggy Taylor, The Parkinson Progression Marker Initiative (PPMI), Progress in Neurobiology, 2011, 95, 4, 629

    CrossRef

  16. 16
    John C. Morgan, Shyamal H. Mehta, Kapil D. Sethi, Biomarkers in Parkinson’s Disease, Current Neurology and Neuroscience Reports, 2010, 10, 6, 423

    CrossRef

  17. 17
    Li Rebekah Feng, Kathleen A. Maguire-Zeiss, Gene Therapy in Parkinsonʼs Disease, CNS Drugs, 2010, 24, 3, 177

    CrossRef

  18. 18
    Edna Grünblatt, Sonja Zehetmayer, Christian P. Jacob, Thomas Müller, Wolfgang H. Jost, Peter Riederer, Pilot study: peripheral biomarkers for diagnosing sporadic Parkinson’s disease, Journal of Neural Transmission, 2010, 117, 12, 1387

    CrossRef

  19. 19
    Brit Mollenhauer, Omar MA El-Agnaf, Katrin Marcus, Claudia Trenkwalder, Michael G Schlossmacher, Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies, Biomarkers in Medicine, 2010, 4, 5, 683

    CrossRef

  20. 20
    Mark W. Mahowald, Michel A. Cramer Bornemann, Carlos H. Schenck, The early and accurate objective diagnosis of RBD—Why should we care?, Movement Disorders, 2010, 25, 13
  21. 21
    John Seibyl, Kenneth Marek, I. George Zubal, The Role of the Core Imaging Laboratory in Multicenter Trials, Seminars in Nuclear Medicine, 2010, 40, 5, 338

    CrossRef

  22. 22
    Kurt A. Jellinger, Parkinson's Disease,